Aequs Shares Plunge 18% After Q2 Loss Widens and Consumer Business EBITDA Breakeven Timeline Stays Open

The Quick Take

• Aequs shares fell 18% after Q2 FY27 results showed a wider-than-expected loss, with management declining to provide a revised timeline for when the consumer business would reach EBITDA breakeven.
• CEO Aravind Melligeri told CNBC-TV18 that the company also revised its capex target, suggesting capital allocation is being actively managed amid ongoing losses.
• The 18% single-session decline reflects investor frustration at the absence of a concrete breakeven roadmap for the consumer segment, which has been loss-making despite growing revenue.

Aequs, an Indian precision manufacturing company with operations in aerospace components and consumer toys/electronics, reported Q2 FY27 results that disappointed sharply. The 18% share price decline came after CEO Aravind Melligeri, speaking directly to CNBC-TV18, declined to provide a revised breakeven timeline for the consumer business — a response that markets interpreted as an implicit acknowledgement that profitability is further away than previously guided. The revised capex target disclosed in the same interaction signals that management is trimming investment to manage cash flow, a common response to extended loss periods in capital-intensive businesses.

Aequs operates at the intersection of two distinct narratives: a strong aerospace business benefiting from India's defence indigenisation push and global aviation MRO expansion, and a consumer business (primarily toy manufacturing) that has required sustained investment to reach scale. The aerospace segment, which includes precision machining for global OEMs and defence platforms, has been growing robustly as India's defence budget expands and global aviation supply chains seek to diversify from China. The consumer business, however, has faced higher-than-expected competitive pressure and ramp costs. The 18% decline reflects markets discounting the aerospace premium to account for consumer drag.

The key forward catalyst for Aequs is a concrete breakeven timeline for the consumer business. Without this, the stock will trade at a discount to pure-play aerospace peers like MTAR Technologies and Data Patterns. Watch Aequs management's next quarterly commentary for any timeline guidance — even a range of 2-4 quarters would reduce uncertainty premium. The aerospace order book is the offsetting positive: if quarterly aerospace revenue continues to grow above 20%, it can sustain the stock even with consumer losses, as investors increasingly value the business on sum-of-parts with the consumer segment treated as a write-down option.

Synthesized from 1 source.